Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Anthony R Carlini, MS
Johns Hopkins Bloomberg School of Public Health
Principal Investigator - Micahel J Bosse, MD
Carolinas Medical Center
Principal Investigator - Rachel Seymour, PhD
Atrium Health Musculoskeletal Institute Research
Principal Investigator - Renan C Castillo, PhD
Johns Hopkins Bloomberg School of Public Health
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University
Redwood City, California, United States
Recruiting - University of California at San Francisco
San Francisco, California, United States
Saam Morshed, MDRecruiting - _university of California, San Francisco
San Francisco, California, United States
Recruiting - University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Recruiting - St Mary'S University/tenent Health
West Palm Beach, Florida, United States
Recruiting - Emory University School of Medicine
Atlanta, Georgia, United States
William Reisman, MDRecruiting - Indiana University School of Medicine - Methodist Hospital
Indianapolis, Indiana, United States
Recruiting - Indiana University/eskenazi Health
Indianapolis, Indiana, United States
Recruiting - University of Kentucky
Lexington, Kentucky, United States
Recruiting - Lsu Health Sciences
New Orleans, Louisiana, United States
Recruiting - University of Maryland , Md Department of Orthopaedics
Baltimore, Maryland, United States
Robert O'Toole, MDRecruiting - Walter Reed Military Medical Center
Bethesda, Maryland, United States
Recruiting - Harvard/mass General/brigham Hospitals
Boston, Massachusetts, United States
Recruiting - Hennepin County Medical Center / Minneapolis
Minneapolis, Minnesota, United States
Andrew Schmidt, MDRecruiting - University of Mississippi Medical Center
Jackson, Mississippi, United States
Recruiting - Dartmouth Hitchcock
Lebanon, New Hampshire, United States
Recruiting - Jamaica Hospital Medical Center
Jamaica, New York, United States
Sanjit Konda, MDRecruiting - University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Recruiting - Atrium Health Carolinas Medical Center
Charlotte, North Carolina, United States
Recruiting - Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, United States
Recruiting - Metrohealth
Cleveland, Ohio, United States
Recruiting - Ohio State University Wexner Medical Center
Columbus, Ohio, United States
Recruiting - University of Oklahoma College of Medicine
Oklahoma City, Oklahoma, United States
Recruiting - Temple University
Philadelphia, Pennsylvania, United States
Recruiting - Brown University/rhode Island Hospital
Providence, Rhode Island, United States
Roman Hayda, MDRecruiting - Rhode Island Hospital/brown University
Providence, Rhode Island, United States
Recruiting - Vanderbilt University Medical Center
Nashville, Tennessee, United States
William T. Obremskey, MDRecruiting - University of Texas Health Science Center - Houston
Houston, Texas, United States
Stephen Warner, MDRecruiting - University of Virginia
Charlottesville, Virginia, United States
David Weiss, MDRecruiting - Inova Fairfax Medical Campus
Falls Church, Virginia, United States
Recruiting - Virginia Commonwealth University Medical Center
Richmond, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 May 2021
- Primary completion
- 30 Sept 2028
- Completion
- 31 Mar 2029
- Last update posted
- 22 Jul 2026
- Registered enrollment
- 600
- Registry id
- NCT04678154
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.